The Yverdon-based company for multi-material cutting tools, Lamina Technologies, was taken over by Triton via its Triton Smaller Mid Cap Fund (TSM).
Tags :Vischer
David Rosenthal, one of the main Swiss experts on data and technology law, has joined VISCHER as head of Data & Privacy group expanding the technology law practice of the firm.
Schneider Group, a Invision portfolio company and one of Switzerland's main freight forwarding companies, has acquired the globally active forwarding agent Nova Traffic with locations in Kloten and Embrach.
Redbiotec, a Swiss developer of a therapeutic vaccine for genital herpes, plans to close CHF 9m Series A round this year
EraCal, a Swiss biotech developing an anti-obesity drug, aims to raise CHF 15m in a Series A round next year, according to Mergermarket
FoRx Therapeutics, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round
VISCHER advised him in this transaction. The team was led by Maxime Chollet (head of Geneva real estate & corporate desks), supported by Nadia Tarolli (tax), Nigar Mustafazade (corporate) and Nina Orth (tax).
From wearables sensors to collect physiological data to DNA’s sequences analysis with AI-based mechanism to online health counseling: numerous digital health solutions are currently being tested, implemented and improved, but Switzerland is still lacking
The Competence Center Banking and Finance at the University of Applied Sciences St.Gallen has started in April 2020 the research project «Independent Evaluation Framework for Security Tokens» co-financed by Innosuisse.
Relief Therapeutics Holding announces the closing of the binding Share Exchange Agreement for the acquisition by Sonnet BioTherapeutics, now a subsidiary of Sonnet BioTherapeutics Holdings
